Redpoint Investment Management Pty Ltd lowered its stake in Clorox Co (NYSE:CLX) by 12.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The fund owned 4,996 shares of the company’s stock after selling 701 shares during the quarter. Redpoint Investment Management Pty Ltd’s holdings in Clorox were worth $765,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the business. Janus Henderson Group PLC boosted its position in Clorox by 28.4% in the first quarter. Janus Henderson Group PLC now owns 1,771,185 shares of the company’s stock worth $284,204,000 after purchasing an additional 391,569 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Clorox by 21.5% in the fourth quarter. Geode Capital Management LLC now owns 1,899,544 shares of the company’s stock valued at $292,347,000 after acquiring an additional 335,835 shares in the last quarter. Martingale Asset Management L P boosted its holdings in shares of Clorox by 152.4% in the first quarter. Martingale Asset Management L P now owns 211,703 shares of the company’s stock valued at $33,971,000 after acquiring an additional 127,816 shares in the last quarter. PNC Financial Services Group Inc. boosted its holdings in Clorox by 65.4% during the first quarter. PNC Financial Services Group Inc. now owns 299,966 shares of the company’s stock worth $48,133,000 after buying an additional 118,660 shares in the last quarter. Finally, Kornitzer Capital Management Inc. KS boosted its holdings in Clorox by 41.1% during the second quarter. Kornitzer Capital Management Inc. KS now owns 402,319 shares of the company’s stock worth $61,599,000 after buying an additional 117,272 shares in the last quarter. Hedge funds and other institutional investors own 75.88% of the company’s stock.

In other news, SVP Denise Garner sold 20,399 shares of Clorox stock in a transaction dated Friday, June 7th. The shares were sold at an average price of $157.61, for a total transaction of $3,215,086.39. Following the sale, the senior vice president now directly owns 4,896 shares in the company, valued at approximately $771,658.56. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Michael R. Costello sold 3,225 shares of Clorox stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $161.34, for a total transaction of $520,321.50. Following the sale, the senior vice president now owns 29,669 shares in the company, valued at $4,786,796.46. The disclosure for this sale can be found here. Insiders sold a total of 29,011 shares of company stock worth $4,575,097 over the last 90 days. Company insiders own 1.40% of the company’s stock.

CLX has been the subject of a number of research analyst reports. Citigroup set a $156.00 target price on shares of Clorox and gave the stock a “hold” rating in a research report on Thursday, May 23rd. Argus downgraded shares of Clorox from a “buy” rating to a “hold” rating in a report on Monday, May 20th. Wells Fargo & Co restated a “hold” rating and set a $153.00 price target on shares of Clorox in a report on Thursday, August 1st. UBS Group raised their price target on shares of Clorox from $110.00 to $128.00 and gave the company a “sell” rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada raised their price target on shares of Clorox to $161.00 and gave the company a “sector perform” rating in a report on Friday, August 2nd. Three research analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have given a buy rating to the company. Clorox currently has an average rating of “Hold” and an average price target of $154.07.

NYSE:CLX traded down $1.07 during midday trading on Thursday, reaching $158.91. The stock had a trading volume of 8,749 shares, compared to its average volume of 1,037,303. Clorox Co has a 1-year low of $141.53 and a 1-year high of $167.70. The firm’s fifty day simple moving average is $159.72 and its 200-day simple moving average is $155.96. The company has a debt-to-equity ratio of 4.09, a current ratio of 0.91 and a quick ratio of 0.55. The stock has a market capitalization of $20.08 billion, a P/E ratio of 25.01, a PEG ratio of 4.95 and a beta of 0.37.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.88 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.84 by $0.04. Clorox had a net margin of 13.20% and a return on equity of 118.88%. The business had revenue of $1.63 billion for the quarter, compared to analyst estimates of $1.69 billion. During the same period last year, the business posted $1.66 EPS. Clorox’s revenue was down 3.8% compared to the same quarter last year. On average, equities research analysts anticipate that Clorox Co will post 6.4 earnings per share for the current fiscal year.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.

Read More: How does a margin account work?

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.